Clinical efficiency of medium and high doses of valsartan in the treatment of patient with arterial hypertension and chronic kidney diseases
- Authors: Maximov ML1, Dralova OV1
-
Affiliations:
- I.M. Sechenov MMA
- Issue: No 4 (2010)
- Pages: 320-322
- Section: Articles
- URL: https://ogarev-online.ru/2313-0245/article/view/337524
- ID: 337524
Cite item
Abstract
The results of the study, which shows the efficiency of antihypertensive and nephroprotektive angiotensin II receptor blocker valsartan in patients with arterial hypertension of and chronic kidney disease. Dose dependence was confirmed nephroprotective and antihypertensive effects of valsartan, and also marked by a high safety profile of the drug in the average and maximum therapeutic doses.
About the authors
M L Maximov
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
O V Dralova
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
Supplementary files
